HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Nigedase in the combined treatment of patients with chronic pancreatitis and enterocolitis].

Abstract
The authors examined the efficacy of a new native agent of lipolytic action (nigedase, made in the USSR) used for the treatment of digestive disorders in 62 patients with chronic diseases of the pancreas and enterocolitis. Nigedase should be taken 1-2 tablets daily for 3-4 weeks. By its lipolytic action nigedase is more active than festal.
AuthorsL V Dudar', A N Erokhina, I L Kliaritskaia
JournalVrachebnoe delo (Vrach Delo) Issue 8 Pg. 75-6 (Aug 1989) ISSN: 0049-6804 [Print] Ukraine
Vernacular TitleNigedaza v kompleksnom lechenii bol'nykh khronicheskim pankreatitom i énterokolitom.
PMID2588539 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Pancreatic Extracts
  • Plant Extracts
  • Tablets
  • festal
  • nigedase
Topics
  • Chronic Disease
  • Combined Modality Therapy
  • Drug Evaluation
  • Enterocolitis (drug therapy)
  • Humans
  • Pancreatic Extracts (therapeutic use)
  • Pancreatitis (drug therapy)
  • Plant Extracts (therapeutic use)
  • Tablets
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: